You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ambrisentan

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes With Diabetic Nephropathy Trial in Worldwide (Sotagliflozin, Ambrisentan, Ambrisentan and Sotagliflozin)

Not yet recruiting
  • Type 1 Diabetes Mellitus With Diabetic Nephropathy
  • Aurora, Colorado
  • +6 more
Oct 2, 2023

Pulmonary Arterial Hypertension Trial in Shanghai (Ambrisentan)

Completed
  • Pulmonary Arterial Hypertension
  • Ambrisentan
  • Shanghai, China
    Renji Hospital
Jun 28, 2022

Exercise-induced Pulmonary Arterial Hypertension Trial in Boston (Ambrisentan)

Completed
Has Results
  • Exercise-induced Pulmonary Arterial Hypertension
  • Ambrisentan
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 5, 2022

Pulmonary Arterial Hypertension Trial (Ambrisentan, Placebo)

Not yet recruiting
  • Pulmonary Arterial Hypertension
  • Ambrisentan
  • Placebo
  • (no location specified)
Jul 13, 2021

Hypertension, Pulmonary Trial in Worldwide (Ambrisentan)

Active, not recruiting
  • Hypertension, Pulmonary
  • Ambrisentan
  • Aurora, Colorado
  • +21 more
Apr 7, 2022

Covid19, Hypoxemia Trial in Spain (Ambrisentan, Placebo)

Recruiting
  • Covid19
  • Hypoxemia
  • Ambrisentan
  • Placebo
  • Gijón, Asturias, Spain
  • +10 more
Aug 4, 2021

Pre-Pulmonary Atrial Hypertension Trial in Denver (Ambrisentan)

Terminated
  • Pre-Pulmonary Atrial Hypertension
  • Ambrisentan
  • Denver, Colorado
    National Jewish Health
Jan 15, 2021

Portopulmonary Hypertension Trial in United States (Ambrisentan)

Completed
Has Results
  • Portopulmonary Hypertension
  • Ambrisentan
  • La Jolla, California
  • +5 more
Dec 16, 2020

VOLIBRIS® (Ambrisentan) (Pulmonary Arterial Hypertension)

Completed
  • Hypertension, Pulmonary
  • Ambrisentan
  • (no location specified)
Sep 2, 2020

Systemic Sclerosis, Shortness of Breath, Pulmonary Hypertension Trial in Los Angeles (Ambrisentan)

Completed
Has Results
  • Systemic Sclerosis
  • +2 more
  • Ambrisentan
  • Los Angeles, California
    David Geffen School of Medicine, University of California, Los A
Oct 28, 2020

Cirrhosis, Portal Hypertension, Ascites Trial in Barcelona, Majadahonda, Madrid (Ambrisentan)

Terminated
  • Cirrhosis
  • +2 more
  • Ambrisentan
  • Barcelona, Catalunya, Spain
  • +5 more
Feb 23, 2021

COVID-19 Trial in Cambridge (EDP1815, Dapagliflozin, Ambrisentan)

Recruiting
  • COVID-19
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jun 9, 2021

Pulmonary Hypertension, Heart Failure With Preserved Ejection Fraction Trial in Dallas (Ambrisentan, Placebo)

Terminated
Has Results
  • Pulmonary Hypertension
  • Heart Failure With Preserved Ejection Fraction
  • Ambrisentan
  • Placebo
  • Dallas, Texas
    UT Southwestern Medical Center
May 15, 2020

Pulmonary Arterial Hypertension Trial in Shanghai (Sulfasalazine, Ambrisentan, Sulfasalazine's )

Recruiting
  • Pulmonary Arterial Hypertension
  • Shanghai, China
    Renji Hospital
Aug 22, 2020

Sickle Cell Anemia Trial in Augusta (Ambrisentan, Placebo)

Completed
  • Sickle Cell Anemia
  • Ambrisentan
  • Placebo
  • Augusta, Georgia
    Augusta University
Apr 1, 2020

Pulmonary Hypertension Trial in Worldwide (Ambrisentan)

Completed
Has Results
  • Pulmonary Hypertension
  • Ambrisentan
  • Birmingham, Alabama
  • +45 more
Sep 8, 2020

Hypoplastic Left Heart Syndrome, Hypoplastic Right-sided Heart Complex Trial in Durham (Ambrisentan, Placebo)

Completed
Has Results
  • Hypoplastic Left Heart Syndrome
  • Hypoplastic Right-sided Heart Complex
  • Ambrisentan
  • Placebo
  • Durham, North Carolina
    Duke Universtiy Hospital
Aug 20, 2019

Systemic Sclerosis, Pulmonary Hypertension Trial in Heidelberg (Ambrisentan, Placebo)

Completed
Has Results
  • Systemic Sclerosis
  • Pulmonary Hypertension
  • Ambrisentan
  • Placebo
  • Heidelberg, Germany
    Thoraxclinic at the University of Heidelberg
Apr 17, 2020

Pulmonary Arterial Hypertension Trial in New Orleans, Charleston (Ambrisentan)

Terminated
Has Results
  • Pulmonary Arterial Hypertension
  • Ambrisentan
  • New Orleans, Louisiana
  • +1 more
Apr 5, 2019

Systemic Sclerosis, Scleroderma Trial in Philadelphia (Ambrisentan)

Completed
Has Results
  • Systemic Sclerosis
  • Scleroderma
  • Ambrisentan
  • Philadelphia, Pennsylvania
    University of Pennsylvania Health System
Nov 26, 2018

Sarcoidosis, Pulmonary Hypertension Trial in Chapel Hill, Charleston (Ambrisentan)

Completed
  • Sarcoidosis
  • Pulmonary Hypertension
  • Ambrisentan
  • Chapel Hill, North Carolina
  • +1 more
Jul 31, 2018

Single Ventricle Fontan Palliation Trial in Saint Louis (Ambrisentan)

Completed
Has Results
  • Single Ventricle Fontan Palliation
  • Ambrisentan
  • Saint Louis, Missouri
    Washington University School of Medicine
May 4, 2018

Vascular Disease Trial in China (ambrisentan)

Completed
Has Results
  • Vascular Disease
  • ambrisentan
  • Harbin, Heilongjiang, China
  • +11 more
May 9, 2017

n Ulcer, Scleroderma, Systemic Trial in Stanford (Ambrisentan)

Completed
Has Results
  • n Ulcer
  • Scleroderma, Systemic
  • Ambrisentan
  • Stanford, California
    Stanford University School of Medicine
Mar 1, 2017

Hypertension, Pulmonary Trial in Worldwide (ambrisentan, tadalafil)

Completed
Has Results
  • Hypertension, Pulmonary
  • Birmingham, Alabama
  • +142 more
Aug 14, 2017